Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InKemia Green Chemicals is a specialized biotechnology company within the InKemia IUCT Group that focuses on applying the principles of green chemistry to pharmaceutical and life science R&D. Headquartered in Spain with operations in the United States, the company leverages a proprietary Green Chemistry-Biotechnology Platform to discover novel small molecules and develop sustainable manufacturing processes for active pharmaceutical ingredients (APIs). InKemia maintains an extensive library of over 200 environmentally benign solvents and a robust pipeline targeting oncology, central nervous system disorders, and inflammatory diseases. The company provides a range of CRO and CMO services, including high-throughput synthesis and biocatalysis, while also advancing its own internal programs through partnerships and licensing. Its scientific direction is notably guided by Dr. Paul Anastas, widely regarded as the 'father of green chemistry.'
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Green Chemicals.